Research progress of immune checkpoint inhibitors in neoadjuvant immunotherapy for dMMR/MSI-H locally advanced colorectal cancer
In recent years, immune checkpoint inhibitors (ICIs) have made great progress in the treatment of colorectal cancer, particularly in the post-line and first-line treatment of dMMR/MSH-H metastatic colorectal cancer patients, demonstrating good clinical outcomes. Currently, the relevant research and...
Saved in:
| Main Authors: | Zhu Xi, Li Yang, Jiang Jun, Li Guoli, Kao Xiaoming |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Colorectal & Anal Surgery
2024-02-01
|
| Series: | 结直肠肛门外科 |
| Subjects: | |
| Online Access: | https://jcas.gxmuyfy.cn/cn/wqll/paper.html?id=67&cateName=2024%E5%B9%B4%20%E7%AC%AC30%E5%8D%B7%20%E7%AC%AC1%E6%9C%9F |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is neoadjuvant immunotherapy feasible for patients with dMMR/MSI−H locally advanced colorectal cancer? a retrospective study
by: Zhenkai Luo, et al.
Published: (2025-08-01) -
Impact of body composition on pathological response to neoadjuvant immunotherapy in dMMR/MSI-H colorectal cancer
by: Ziyang Zeng, et al.
Published: (2025-05-01) -
Advances and future perspectives of neoadjuvant immunotherapy in colorectal cancer
by: ZHANG Yuyang, LIU Qian
Published: (2025-07-01) -
Updates on DNA Repair Gene Deficiency in Colorectal Cancer (dMMR)
by: Gustavo Sevá-Pereira, et al.
Published: (2025-03-01) -
Insights into immune-related adverse events in colorectal cancer patients receiving neoadjuvant immunotherapy: findings from a multicenter registry study
by: Chentong Wang, et al.
Published: (2025-06-01)